Monday, March 24, 2014
University of Maryland School of Medicine Dean E. Albert Reece, M.D., Ph.D., M.B.A., has appointed W. Jonathan Lederer, M.D., Ph.D., as the permanent director of the Center for Biomedical Engineering and Technology (BioMET).
BioMET is an organized research center that is a joint effort between the University of Maryland School of Medicine at the University of Maryland, Baltimore (UMB) and the Fischell Department of Bioengineering, Clark School of Engineering at the University of Maryland in College Park (UMCP). The center brings together basic biomedical researchers with engineers to develop new strategies and new devices to treat diseases.
“Dr. Lederer is an exceptional researcher and educator whose accomplishments in physiology have not only propelled the School of Medicine, but have also led BioMET to the discovery of incredible breakthroughs in the study of the heart and vascular system,” says Dean Reece, who is also Vice President for Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor at the School of Medicine. “His excellent leadership and commitment to research will continue to set a high bar for BioMET.”
Dr. Lederer, who is also a professor in the Department of Physiology, said, “I am delighted to be appointed the permanent director of the Center for Biomedical Engineering and Technology. It is an honor to work with BioMET’s outstanding faculty and staff, who are working at the frontiers of experimental science. They are making brilliant advances in brain and cardiac signaling, in cell and molecular biology, in signaling chemistry and molecular trafficking, and in exploiting the latest technology and engineering,” he said.
Dr. Lederer is excited to see how his team will partner with others on campus who are also seeking out new innovations. “We certainly fit in wonderfully with our colleagues in all the schools at UMB, and particularly well with the researchers and educators in the School of Medicine,” he said. “I am also eager to extend our on-going collaborative work with our colleagues in the Fischell Department of Bioengineering at UMCP. I think BioMET can bridge science, communication and education between UMCP and UMB and extend the reach of the ‘MPowering the State’ initiative. I am also eager and excited by the opportunity to work with Dean Reece as well as the other Center and Institute Directors and Department Chairs. This is a wonderful time to be doing basic and applied medical research, even if it is an economically challenged period.”
Dr. Lederer received a B.A. from Harvard University and obtained his Ph.D. and M.D. degrees from Yale University. After completing an internship in Medicine at the University of Washington, Seattle, Dr. Lederer was awarded a British-American heart fellowship at Oxford University in Oxford, England. He joined UMB in 1979 and began working at BioMET’s predecessor center at the University of Maryland Biotechnology Institute in 1995. BioMET was formed at the School of Medicine in 2009 after the dissolution of the centers in the University of Maryland Biotechnology Institute.
Dr. Lederer is a highly-regarded physician-scientist who has published more than 225 research papers, in such prestigious journals as Science and Nature. He has also received continuous funding from the National Institutes of Health since 1980. Dr. Lederer currently has four active grants, totaling more than $8 million. He has received a number of awards, including an American Heart Association Established Investigatorship; an NIH Merit Award; The Biophysical Society Cole Award; and the University System of Maryland Regents’ Award for Excellence in Research in 1999. He has delivered more than 10 international special lectureships since 2007, and been named a fellow of the American Heart Association, the Biophysical Society, and the International Society for Heart Research. Dr. Lederer was also recently named UMB’s 2013 Researcher of the Year.